(Q48375432)

11 February 2018

review article

1 reference

title

Chronic fatigue syndrome and fibromyalgia. Dilemmas in diagnosis and clinical management. (English)

1 reference

11 February 2018

main subject

fibromyalgia

0 references

chronic fatigue syndrome

1 reference

Demitrack MA

1

1 reference

11 February 2018

publication date

1 September 1998

1 reference

11 February 2018

Psychiatric Clinics of North America

published in

1 reference

11 February 2018

volume

21

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

671-92, viii

1 reference

11 February 2018

Psychological factors associated with primary fibromyalgia syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Serum neopterin and interleukin-6 levels in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Interleukin-2 and the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Clinical characteristics of fibrositis. II. A "blinded," controlled study using standard psychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Predictors of chronic "postviral" fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Severe fibromyalgia after hypophysectomy for Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

On the various forms of corticosteroid withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Chronic Mononucleosis Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

The overdiagnosis of fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Immunological and physiological changes associated with induced positive and negative mood.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

A Lecture on Lumbago: Its Lessons and Analogues: Delivered at the National Hospital for the Paralysed and Epileptic.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

A Comprehensive Immunological Analysis in Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

The psychiatric status of patients with the chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Chronic fatigue syndrome: a working case definition.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Natural Killer Cells and the Post Viral Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Fibromyalgia and major affective disorder: a controlled phenomenology and family history study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Partial sleep deprivation reduces natural killer cell activity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Immune function in chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Somatization and depression in fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Immunologic abnormalities in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Chronic fatigue syndrome: clinical condition associated with immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Serum Levels of Lymphokines and Soluble Cellular Receptors in Primary Epstein-Barr Virus Infection and in Patients with Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Depression among patients with a chief complaint of chronic fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Population based study of fatigue and psychological distress

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Fibrositis and psychologic disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Precipitating factors for the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Follow up of patients presenting with fatigue to an infectious diseases clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Circulating lymphokine levels in the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Lymphocyte phenotype and function in the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Serologic and Virologic Epidemiology of Epstein-Barr Virus: Relevance to Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Corticotropin releasing factor produces behavioural activation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Postinfectious fatigue: prospective cohort study in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

The existence of a fatigue syndrome after glandular fever.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Longitudinal study of outcome of chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Salivary cortisol profiles in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970031-9

7 January 2021

10.1016/S0193-953X(05)70031-9

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018